- Company
- Hanmi-GC sign MOU for new drug R&D partnership
- by Chon, Seung-Hyun Mar 2, 2020 06:21am
- Hanmi Pharmaceutical and GC Pharma have inked the first new drug R&D partnership deal in the history. Two companies would concentrate their R&D capacity to increase the possibility of successful development of an innovative new drug. On Feb. 27, Hanmi Pharmaceutical and GC Pharma have announced the two have signed MOU on co-developing
- Opinion
- [Reporter’s View] Fake news deadlier than novel virus
- by An, Kyung-Jin Mar 2, 2020 06:21am
- “Don’t talk to anyone! Don’t touch anything!” These were the catchphrases printed on marketing poster of a movie Contagion, released in September 2011. Starring beloved Hollywood stars like Gwyneth Paltrow and Kate Winslet, the movie focused on an unknown infectious disease creating a global crisis. A woman, who came back from a busin
- Policy
- Additional indication of interferon or Kaletra is recognized
- by Kim, Jung-Ju Mar 2, 2020 06:20am
- The government recognizes widespread benefits of antiviral drugs even if it is not approved indication, including interferon, as well as AIDS treatments such as Kaletra for the treatment of The Ministry of Health and Welfare issued a partial amendment of 'Details on the Pharmaceutical Reimbursement Listing Standard and Method' on the 20th a
- Company
- Panicking with first confirmed COVID-19 in industry
- by Chon, Seung-Hyun Feb 28, 2020 06:03am
- Korean pharmaceutical industry now has a first confirmed case of the 2019 novel coronavirus, COVID-19. Working at a research laboratory without much of external interaction, the infected employee is not expected to create a severe impact. But pharmaceutical companies are reinforcing precautionary measures against disease transmission. More
- Policy
- COVID-19 treatment is active in domestic clinical
- by Lee, Tak-Sun Feb 28, 2020 06:02am
- As the number of Korean COVID-19 patients has soared, the development of therapeutics is also active. In addition to multinational pharmaceutical company Gillead, domestic pharmaceutical company Komipharm has applied for clinical trial approval of the pipelines, and Immunemed's antiviral drug was approved for therapeutic use. Gilead said t
- Policy
- A set of three bills about COVID-19 was passed
- by Lee, Jeong-Hwan Feb 28, 2020 06:01am
- The National Assembly held a plenary session at 2 pm on the 26th and passed 'a set of three bills about COVID-19' and a proposal for a special committee for countermeasures against the COVID-19. A set of three bills about COVID-19 came into effect after government promulgation, and the ruling & the opposition parties had the authority to a
- COVID-19: International exhibition and conferences canceled
- by Choi, sun Feb 28, 2020 06:01am
- A number of organizations waited and watched the rapid spread of COVID-19 have decided to call of their key events. The organizers of international exhibitions like annual Medical Korea and international conferences had initially planned to push on with the schedule, but decided to given up on the events due to the concern of the outbreak.
- Policy
- What is the solution to the COVID-19 crisis?
- by Lee, Jeong-Hwan Feb 28, 2020 06:01am
- To reduce the number of serious and death patients, the burden on medical institutions should be minimized. Abandoning the idea that a hospital should see a minor patient unconditionally, and dispatching a medical team, but it is possible to efficiently manage infection by securing a management bed of a serious patient. (Professor Jung-sik Eo
- Company
- Pharmaceutical staff struggle to work from home
- by Jung, Hye-Jin Feb 27, 2020 06:35am
- In the aftermath of COVID-19, face-to-face sales activities at pharmaceutical companies have declined, and alternative sales activities are increasing online. From academic papers provided by the company to light-looking articles created by the company. Pharmaceutical officials are working hard to maintain relationships with hospital doctors.
- InterView
- On how Eisa’s intrapreneur ‘HeLpy’ is ‘happy’
- by Eo, Yun-Ho Feb 27, 2020 06:35am
- Lately, companies emphasize a notion of internal entrepreneurship, also known as ‘intrapreneurship.’ For companies, innovation is not an option anymore. And this is the time when intrapreneurship becomes the source of internal innovation. So these days, ‘internal venture’ is popular among companies. Without massive investment, an in
